載入...
The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
The paper discusses prospects for prescribing tumor necrosis factor-α (TNF-α) inhibitor biosimilars, their interchangeability with original drugs for inflammatory joint diseases. It describes clinical cases when original infliximab is replaced with its biosimilar Flammagis for ankylosing spondylitis...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Russo |
| 出版: |
IMA-PRESS LLC
2020-05-01
|
| 叢編: | Современная ревматология |
| 主題: | |
| 在線閱讀: | https://mrj.ima-press.net/mrj/article/view/1027 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|